Literature DB >> 24117159

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma.

Graham P Collins1, Anne N Parker, Christopher Pocock, Irfan Kayani, Anna Sureda, Tim Illidge, Kirit Ardeshna, David C Linch, Karl S Peggs.   

Abstract

Entities:  

Keywords:  Hodgkin lymphoma; chemotherapy; relapse; transplantation

Mesh：

Year:  2013        PMID： 24117159     DOI： 10.1111/bjh.12582

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  How I treat advanced Hodgkin lymphoma - a global view.

Authors:  Peter Hokland; Mansi Shah; Kevin David; Andrew Evens; Rebecca Auer; Rifca Ledieu; Stefanie Kreissl; Paul J Bröckelmann; Peter Borchmann; Anu Korula; Vikram Mathews; Weerapat Owattanapanich; Judith Trotman
Journal:  Br J Haematol       Date:  2020-06-19       Impact factor: 6.998

2.  Relapsed Hodgkin's lymphoma in pregnancy: A case review.

Authors:  Rhiannon George-Carey; Maryam Parisaei; Wiece Koniman; Micaela Pluckinski; Jonathan Lambert
Journal:  Obstet Med       Date:  2017-10-11

3.  Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.

Authors:  María Marta Rivas; Mariano Berro; María Virginia Prates; Sebastián Yantorno; Lorena Fiad; Jorge Alberto Arbelbide; Ana Lisa Basquiera; Gonzalo Ariel Ferini; Juan José García; Pablo Andrés García; Leandro Riera; Gustavo Jarchum; Alfredo Baso; Juan Real; Martín Castro; Gregorio Jaimovich; Juliana Martinez Rolón; Cecilia Foncuberta; Silvia Saba; Gustavo Kusminsky
Journal:  Bone Marrow Transplant       Date:  2019-08-21       Impact factor: 5.483

Review 4.  Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma.

Authors:  Craig Moskowitz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

5.  SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.

Authors:  A Rueda Domínguez; J Alfaro Lizaso; L de la Cruz Merino; J Gumá I Padró; C Quero Blanco; J Gómez Codina; M Llanos Muñoz; N Martinez Banaclocha; D Rodriguez Abreu; M Provencio Pulla
Journal:  Clin Transl Oncol       Date:  2015-10-26       Impact factor: 3.405

6.  Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.

Authors:  J Radford; P McKay; R Malladi; R Johnson; A Bloor; F Percival; A Sureda; K S Peggs
Journal:  Bone Marrow Transplant       Date:  2017-01-16       Impact factor: 5.483

Review 7.  Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma.

Authors:  Eleonora Calabretta; Francesco d'Amore; Carmelo Carlo-Stella
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

Review 8.  Immunotoxin - a new treatment option in patients with relapsed and refractory Hodgkin lymphoma.

Authors:  Barbara Jezersek Novakovic
Journal:  Radiol Oncol       Date:  2015-11-27       Impact factor: 2.991
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.